# Cabrellis Pharmaceuticals Corporation

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cabrellis-pharmaceuticals

- Industry: Pharmaceuticals
- Headquarters: San Diego, US
- Total disclosed funding: $27M
- Latest round: Series A (Aug 7, 2006)
- Investors on record: 8

## About

Cabrellis Pharmaceuticals Corporation engages in the development of important therapies for the treatment of cancer.

## Funding rounds

- Series A, Aug 7, 2006, $27M — Domain Associates, Forward Ventures, RBC Capital Markets, Lilly Ventures, RiverVest Ventures Partners, SR One, ProQuest Investments, Novo Holdings A/S

## Investors

- Domain Associates (https://capitalatlas.ai/funds/domain-associates) — Series A
- Forward Ventures (https://capitalatlas.ai/funds/forward-ventures) — Series A
- RBC Capital Markets (https://capitalatlas.ai/funds/rbc-capital-markets) — Series A
- Lilly Ventures (https://capitalatlas.ai/funds/lilly-ventures) — Series A
- RiverVest Ventures Partners (https://capitalatlas.ai/funds/rivervest-ventures-partners) — Series A
- SR One (https://capitalatlas.ai/funds/sr-one) — Series A
- ProQuest Investments (https://capitalatlas.ai/funds/proquest-investments) — Series A
- Novo Holdings A/S — Series A